Back to mobile site

Medicines Co. (MDCO) Misses Q1 EPS by 20c

April 26, 2017 7:17 AM EDT

Medicines Co. (NASDAQ: MDCO) reported Q1 EPS of ($1.44), $0.20 worse than the analyst estimate of ($1.24). Revenue for the quarter came in at $24.2 million versus the consensus estimate of $34.08 million.

For earnings history and earnings-related data on Medicines Co. (MDCO) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance

Related Entities

Earnings